Position in HLN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$184,924
-$18,034 QoQ
Shares Held
18,474
-8.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PFG Investments, LLC holds $1,786,204 across 7 Drug Manufacturers - Specialty & Generic names. HLN ranks #5 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
19,865 | $598,333 | |
| 2 | VTRS |
Viatris Inc
|
23,123 | $312,391 | |
| 3 | PRGO |
PERRIGO Co plc
|
24,705 | $265,331 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
350 | $207,543 | |
| 5 | HLN |
Haleon plc
This page
|
18,474 | $184,924 | |
| 6 | AQST |
Aquestive Therapeutics, Inc.
|
31,101 | $129,069 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
13,696 | $88,613 |
All Filings in HLN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $184,924 | 18,474 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $202,958 | 20,075 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $189,625 | 21,140 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $224,697 | 21,668 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $219,177 | 21,300 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $211,683 | 22,189 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $266,002 | 25,142 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $203,625 | 24,652 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $168,450 | 19,841 | Shares | Sole | 2024-04-22 | |
| No filing history on record for this holder in this stock. | ||||||